专家文章 | 周永健

搜索
登录

热心肠智库专家文章 | 周永健

2023

CARapamycin extenuates experimental colitis by modulating the gut microbiota

J GASTROEN HEPATOL, 10.1111/jgh.16381

CAMdivi1 ameliorates mitochondrial dysfunction in non-alcoholic steatohepatitis by inhibiting JNK/MFF signaling

J GASTROEN HEPATOL, 10.1111/jgh.16372

CAHepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota

J GASTROEN HEPATOL, 10.1111/jgh.16359

Engineering siRNA-loaded and RGDfC-targeted selenium nanoparticles for highly efficient silencing of DCBLD2 gene for colorectal cancer treatment

10.1186/s11671-023-03870-0

CAPattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy

FRONT ENDOCRINOL, 10.3389/fendo.2023.1145392

2022

CAFecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea

OXID MED CELL LONGEV, 10.1155/2022/5121496

点击查看热心肠日报解读

CAFirst Application of Fecal Microbiota Transplantation in Adult Asperger Syndrome With Digestive Symptoms-A Case Report

FRONT PSYCHIATRY, 10.3389/fpsyt.2022.695481

CAGut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Front Nutr, 10.3389/fnut.2021.818902

2021

CACpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients

J ONCOL, 10.1155/2021/2715694

CASelection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile

BMC Microbiol, 10.1186/s12866-021-02342-8

CAFecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis

J DERMATOL, 10.1111/1346-8138.16169

CAIdentification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients

J ONCOL, 10.1155/2021/9949492

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808

CAUnconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption

FPHAR, 10.3389/fphar.2021.654808